NCT03086265

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Laser Laryngeal Surgery

The Safety and Efficacy of the Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for Laser Laryngeal Surgery

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Stanford University · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to investigate whether laser laryngeal surgery can be safely and potentially more effectively performed without the use of tracheal intubation or jet ventilation, under completely tubeless conditions. The patient's gas exchange will be supported by rapid insufflation of high-flow oxygen through specialized nasal cannula: the so called Transnasal Humidified Rapid- Insufflation Ventilatory Exchange (THRIVE).

Conditions

• Otorhinolaryngologic Surgical Procedures
• Laser Therapy

Interventions

Type	Name	Description
DEVICE	THRIVE	active nasal oxygen delivery system
DEVICE	Endotracheal tube	Plastic tube for supporting ventilation during surgery

Timeline

• Start date: 2017-03-24
• Primary completion: 2019-02-26
• Completion: 2019-02-26
• First posted: 2017-03-22
• Last updated: 2020-03-17
• Results posted: 2020-03-17

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study